Gateway drug theory

Gateway drug theory (alternatively, stepping-stone theory, escalation hypothesis, or progression hypothesis) is a comprehensive catchphrase for the medical theory that the use of a psychoactive drug can be coupled to an increased probability of the use of further drugs. Possible causes are biological alterations in the brain due to the earlier drug and similar attitudes of users across different drugs (common liability to addiction). Scientific investigation of the possible causes is considered important for health policy concerning education and law making.^[1]

Sequence of first-time use

General concept

The concept of gateway drug is based on observations that the sequence of first-time use of different drugs is not random but shows trends. On the basis of established techniques of longitudinal studies such trends can be described precisely in terms of statistical probability. As to the interpretation of the observed trends, it is important to note the difference between sequence and causation. Both may – but need not – be coupled, a question which is subject of further research, e.g., by physiological experiments.^[2]

Examples of trends

From a sample of 6,624 persons who had not used other illegal drugs before their cannabis consumption the overall probability of later use of further illegal drugs was estimated to be 44.7%. Subgroup analyses showed that personal and social conditions, such as gender, age, marital status, mental disorders, family history of substance abuse, Ethnicity, Urbanicity, and educational attainment influenced the height of probability.^[3]

In a sample of 27,461 persons who showed no signs of alcohol use disorder (AUD) before their cannabis consumption a second examination three years later revealed a five times higher rate (500%) of AUD compared to a control group that had not consumed cannabis. In another sample of 2,121 persons who already had AUD at the first examination the rate of persistence of AUD three years later was 74% higher in the group of Cannabis consumers than in the group of non-consumers.^[4]

A study of drug use of 14,577 US 12th graders showed that alcohol consumption was associated with an increased probability of later use of tobacco, cannabis, and other illegal drugs.^[5]

Causes

Because a sequence of first-time use can only indicate the possibility – but not the fact – of an underlying causal relation, different theories concerning the observed trends were developed. The scientific discussion (state of 2016) is dominated by two concepts, which appear to cover almost all possible causal connections if appropriately combined. These are the theories of biological alterations in the brain due to an earlier drug use and the theory of similar attitudes across different drugs.^[1][6][7]

Alterations in the brain

In animals it is relatively simple to determine if consumption of a certain drug increases the later attraction of another drug. In rats, cannabis consumption – earlier in life – increased the self-administration of heroin,^[8] morphine,^[9] and also nicotine.^[10] There were direct indications that the alteration consisted of lasting anatomical changes in the reward system of the brain.^[8] The importance of these findings for the reward system in the human brain in relation to the liability to the use of further drugs has been pointed out in several reviews.^[11][12][13]

In mice nicotine increased the probability of later consumption of cocaine and the experiments permitted concrete conclusions on the underlying molecular biological alteration in the brain.^[14] The biological changes in mice correspond to the epidemiological observations in humans that nicotine consumption is coupled to an increased probability of later use of cannabis and cocaine.^[15]

Personal and social factors

According to the concept of similar attitudes across different drugs (common liability to addiction) several personal and environmental factors can lead to a generally increased interest in various drugs. The sequence of first-time use would then depend on the given social and economic conditions.^[1][16] The concept received support from a large-scale genetic analysis that showed a genetic basis for the connection of the prevalence of cigarette smoking and cannabis use during the life of a person.^[17]

The results of a twin study presented indications that familial genetic and familial environmental factors do not fully explain these associations, and are possibly only relevant for sequences of some drugs. In 219, same-sex Dutch twin pairs one co-twin had used cannabis before the age of 18 whereas the other had not. In the cannabis group the lifetime prevalence of later use of party drugs was four times higher and the lifetime prevalence of later use of hard drugs was seven times higher than in the non-cannabis group. The authors concluded that at least family influences – both genetic and social ones – could not explain the differences. The study noted that - besides a potential causal role of cannabis use - non shared environment factors could play a role in the association such as differing peer affiliations that preceded the cannabis use.^[18][19]

History

While the phrase gateway drug first appeared in the 1980s, the underlying ideas had already been discussed since the 1930s by using the phrases stepping-stone theory, escalation hypothesis, or progression hypothesis.^[20][21]

The scientific and political discussion has intensified since 1975 after the publications of several longitudinal studies by Denise Kandel and others.^[22][23][24] Denise Kandel is Professor of Sociomedical Sciences and Psychiatry at Columbia University and Head of the Department of Epidemiology of Substance Abuse at the New York State Psychiatric Institute (since 1956 married to Eric Kandel, neurobiologist and recipient of the 2000 Nobel Prize in Physiology or Medicine).

See also

• Substance dependence
• Substance abuse prevention
• Drug policy
• Tobacco and other drugs

References

Further reading

Scientific textbooks

• D. B. Kandel (Ed.): Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis, Cambridge University Press, 2002, ISBN 978-0-521-78969-1.
• Wayne Hall, Rosalie Liccardo Pacula: Is cannabis a gateway drug? In: Same authors: Cannabis Use and Dependence. Public Health and Public Policy, Cambridge University Press, Cambridge, UK, New York, USA, 2003, ISBN 978-0-521-80024-2, chapt. 10, pp. 104–114.

Lay scientific books

• Mark A.R. Kleiman, Jonathan P. Caulkins, Angela Hawken: Is marijuana a "gateway drug"? In: Same authors: Drugs and Drug Policy. What Everyone Needs to Know, Oxford University Press, 2011, ISBN 978-0-19-983138-8, chapt. 4, question 8, pp. 81–83.

State of research before 1974

• Goode, Erich (1974). "Marijuana use and the progression to dangarous drugs". In Miller, Loren. Marijuana Effects on Human Behavior. Burlington: Elsevier Science. pp. 303–338. ISBN 978-1-4832-5811-9. 

External links

• Is marijuana a gateway drug?, website of the National Institute on Drug Abuse at the National Institutes of Health.
• Virginia Gewin: Smoking stokes cocaine cravings: Molecular mechanism found for controversial 'gateway drug' hypothesis, Nature News, November 2, 2011.
• Video: Eric Kandel and Denise Kandel: E-Cigarettes May Promote Illicit Drug Use and Addiction, Columbia University, January 16, 2015.